Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.
Annals of Clinical and Translational Neurology|August 8, 2023
A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairmentMark Monane, Kim G Johnson, B Joy Snider, et al.
Molecular Neurodegeneration|May 2, 2021
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysisTim West, Kristopher M Kirmess, Matthew R Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2025
Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementiaKarly A Cody, Lianlian Du, Rachel L Studer, et al.
Annals of Clinical and Translational Neurology|March 28, 2023
Independent study demonstrates amyloid probability score accurately indicates amyloid pathologyIlana Fogelman, Tim West, Joel B Braunstein, et al.
JAMA Neurology|July 28, 2024
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive ImpairmentShorena Janelidze, Nicolas R Barthélemy, Gemma Salvadó, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 17, 2024
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trialDoris Patricia Molina-Henry, Rema Raman, Andy Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Generating synthetic tau-PET scans in Alzheimer's disease from MRI, blood biomarkers and demographics with deep learningLinda Karlsson, Olof Strandberg, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 29, 2026
Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's diseaseJulie Lee, Emily Olafson, Balazs Toth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2025
Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PETPetrice M Cogswell, Heather J Wiste, Stephen D Weigand, et al.
Pageof 8